{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:12:10Z","timestamp":1781835130904,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12325-013-0014-7","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:23:11Z","timestamp":1362784991000},"page":"260-270","source":"Crossref","is-referenced-by-count":25,"title":["Ocular Surface Tolerability of Prostaglandin Analogs and Prostamides in Patients with Glaucoma or Ocular Hypertension"],"prefix":"10.1007","volume":"30","author":[{"given":"Andrew C. S.","family":"Crichton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","volume":"45","author":"DF Woodward","year":"2001","unstructured":"Woodward DF, Krauss AH, Chen J, et al. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45:S337\u2013S345.","journal-title":"Surv Ophthalmol"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.102.047837","volume":"305","author":"DF Woodward","year":"2003","unstructured":"Woodward DF, Krauss AH, Chen J, et al. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). J Pharmacol Exp Ther. 2003;305:772\u2013785.","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.eye.6701674","volume":"19","author":"HD McKee","year":"2005","unstructured":"McKee HD, Gupta MS, Ahad MA, Salda\u00f1a M, Innes JR. First-choice treatment preferences for primary open-angle glaucoma in the United Kingdom. Eye (Lond). 2005;19:923\u2013924.","journal-title":"Eye (Lond)"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14740338.6.1.45","volume":"6","author":"G Holl\u00f3","year":"2007","unstructured":"Holl\u00f3 G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007;6:45\u201352.","journal-title":"Expert Opin Drug Saf"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.exer.2008.08.022","volume":"88","author":"KP Cracknell","year":"2009","unstructured":"Cracknell KP, Grierson I. Prostaglandin analogues in the anterior eye: their pressure lowering action and side effects. Exp Eye Res. 2009;88:786\u2013791.","journal-title":"Exp Eye Res"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02850114","volume":"20","author":"MB Abelson","year":"2003","unstructured":"Abelson MB, Mroz M, Rosner SA, Dirks MS, Hirabayashi D. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension. Adv Ther. 2003;20:1\u201313.","journal-title":"Adv Ther"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2004.03.006","volume":"138","author":"BC Leal","year":"2004","unstructured":"Leal BC, Medeiros FA, Medeiros FW, Santo RM, Susanna R, Jr. Conjunctival hyperemia associated with bimatoprost use: a histopathologic study. Am J Ophthalmol. 2004;138:310\u2013313.","journal-title":"Am J Ophthalmol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00061198-200112000-00008","volume":"10","author":"GD Novack","year":"2001","unstructured":"Novack GD, Evans R. Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization. J Glaucoma. 2001;10:483\u2013486.","journal-title":"J Glaucoma"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0939-6411(01)00246-6","volume":"53","author":"P Furrer","year":"2002","unstructured":"Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm. 2002;53:263\u2013280.","journal-title":"Eur J Pharm Biopharm"},{"key":"14_CR10","first-page":"1255","volume-title":"Medical Toxicology","author":"TR Caraccio","year":"2004","unstructured":"Caraccio TR, McGuigan MA. Benzalkonium chloride. In: Dart RC, ed. Medical Toxicology, 3rd ed. New York, NY: Lippincott Williams & Williams; 2004:1255\u20131257.","edition":"3rd ed."},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.ico.0000183538.53017.69","volume":"25","author":"C Charnock","year":"2006","unstructured":"Charnock C. Are multidose over-the-counter artificial tears adequately preserved? Cornea. 2006;25:432\u2013437.","journal-title":"Cornea"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jop.2009.0134","volume":"26","author":"JT Whitson","year":"2010","unstructured":"Whitson JT, Trattler WB, Matossian C, Williams J, Hollander DA. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension. J Ocul Pharmacol Ther. 2010;26:287\u2013292.","journal-title":"J Ocul Pharmacol Ther"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29:312\u2013334.","journal-title":"Prog Retin Eye Res"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2415-11-14","volume":"11","author":"GF Schwartz","year":"2011","unstructured":"Schwartz GF, Kotak S, Mardekian J, Fain JM. Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical\/pharmacy claims databases. BMC Ophthalmol. 2011;11:14.","journal-title":"BMC Ophthalmol"},{"key":"14_CR15","first-page":"292","volume-title":"The Preocular Tear Film in Health, Disease and Contact Lens Wear","author":"EJ Champeau","year":"1986","unstructured":"Champeau EJ, Edelhauser HF. Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. In: Holly FJ, ed. The Preocular Tear Film in Health, Disease and Contact Lens Wear. Lubbock, TX: Dry Eye Institute; 1986:292\u2013302."},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-4835(61)80006-7","volume":"1","author":"S Mishima","year":"1961","unstructured":"Mishima S, Maurice DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res. 1961;1:39\u201345.","journal-title":"Exp Eye Res"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1097\/OPX.0b013e318194e962","volume":"86","author":"NL Himebaugh","year":"2009","unstructured":"Himebaugh NL, Begley CG, Bradley A, Wilkinson JA. Blinking and tear break-up during four visual tasks. Optom Vis Sci. 2009;86:E106\u2013E114.","journal-title":"Optom Vis Sci"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0014-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T09:05:34Z","timestamp":1498035934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0014-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0014-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}